Julien Roux on Muck Rack

Julien Roux

As seen in: TF1 +, Wiley Online Library, Science Magazine, Cell Press, Cell Reports Medicine, medRxiv, aoshearman.com, Revue Banque
Grand reporter service société @TF1Info Spécialiste Économie (2021-2025) Santé (2019-2021) et Éducation (2015-2019). Info en continu à @LCI de 2003 à 2015
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Julien

Contact Julien, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A&O Shearman advised the banks on the refinancing of 74Software

|
By Julien Roux, Yasmine Sefraoui, Amance Tailliandier
| aoshearman.com
A&O Shearman advised a banking syndicate in connection with the refinancing of the term loans and revolving credit facility of 74Software, an international enterprise software publisher. The transaction refinanced the group’s existing bank debt, consisting of a EUR120 million revolving credit facility and two term loans of EUR80m and EUR120m, respectively, maturing between 2027 and 2029.
Open in Who Shared Issue with article?

Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans

|
By Henning Tim Langer, Natalie Gilmore, Christopher Hayden, Julien Roux, Bruno Bariohay, Thaïs Rouquet, Manar Awada, Julie Marcotorchino, Lorrine Bournot, Elizabeth R. Nunn, Paul M. Titchenell, Daniela Liskiewicz, Timo Müller, Oluwaseun Anyiam, Philip J Atherton, Iskandar Idris, Andreas Hentschel , Andreas Roos, Natalie Haritonow, Kristina Norman, Ursula Müller-Werdan, Keith Baar
| Cell Reports Medicine
Keywords GLP-1 muscle loss obesity incretins wasting weight loss atrophy function muscle mass Introduction Globally, over 1 billion people suffer from obesity.1 Incretin-based drugs offer a powerful treatment option for patients with obesity (PWO).
Open in Who Shared Issue with article?

A&O Shearman advises banks on financing of ENGIE’s acquisition of UK Power Networks

|
By Julien Roux, Mathieu Vignon, Virginie Chatte, Diana Billik, Tristan Jambu-Merlin, Quitterie d'Andoque, Olivier Thebault, Jade Billere-Mellet, Benedicte Cheyrou-Lagreze, Maggie Casteel
| aoshearman.com
A&O Shearman acted on the establishment of a GBP10.8bn bridge facility, arranged and underwritten by Bank of America and BNP Paribas, to finance ENGIE’s acquisition of UK Power Networks (UKPN), as well as on ENGIE’s capital increase of approximately EUR3bn carried out through an accelerated private placement with qualified investors.
Open in Who Shared Issue with article?
See all 10 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Julien

Contact Julien, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified